Rating Coverage: American Vanguard (AVD) Hit With Upgrade by Piper Jaffray, Time to Buy?

November 28, 2016 - By Peter Kolinski

Rating Coverage:  American Vanguard (AVD) Hit With Upgrade by Piper Jaffray, Time to Buy?

American Vanguard (AVD) Upgrade

Piper Jaffray gave American Vanguard (AVD) shares a new Neutral rating in a a report revealed on 28 November. This is raise from the previous Underweight rating.

About 66,561 shares traded hands. American Vanguard Corp. (AVD) has risen 10.80% since April 25, 2016 and is uptrending. It has outperformed by 4.78% the S&P500.

Analysts await American Vanguard Corp. (NYSE:AVD) to report earnings on March, 7. They expect $0.17 earnings per share, up 70.00% or $0.07 from last year’s $0.1 per share. AVD’s profit will be $5.08 million for 26.62 P/E if the $0.17 EPS becomes a reality. After $0.10 actual earnings per share reported by American Vanguard Corp. for the previous quarter, Wall Street now forecasts 70.00% EPS growth.

Insitutional Activity: The institutional sentiment increased to 1.4 in 2016 Q2. Its up 0.70, from 0.7 in 2016Q1. The ratio increased, as 19 funds sold all American Vanguard Corp. shares owned while 44 reduced positions. 12 funds bought stakes while 32 increased positions. They now own 21.56 million shares or 3.36% less from 22.31 million shares in 2016Q1.

The New York-based Alliancebernstein L P has invested 0% in American Vanguard Corp. (NYSE:AVD). State Board Of Administration Of Florida Retirement Sys accumulated 37,938 shares or 0% of the stock. Parametric Port Assoc Ltd Liability Company last reported 0% of its portfolio in the stock. Schwab Charles Invest Mgmt holds 86,810 shares or 0% of its portfolio. Globeflex Cap Ltd Partnership reported 71,706 shares or 0.3% of all its holdings. Geode Capital Mgmt Ltd Liability has invested 0% of its portfolio in American Vanguard Corp. (NYSE:AVD). Ls Invest Limited Company reported 838 shares or 0% of all its holdings. The Connecticut-based Aqr Capital Lc has invested 0% in American Vanguard Corp. (NYSE:AVD). Janney Montgomery Scott Ltd accumulated 15,400 shares or 0% of the stock. Indexiq Advsrs Ltd holds 7,996 shares or 0.01% of its portfolio. Paradigm Asset Mgmt Llc last reported 1,900 shares in the company. Northern holds 383,175 shares or 0% of its portfolio. Blackrock Institutional Na, a California-based fund reported 702,991 shares. Creative Planning holds 0% of its portfolio in American Vanguard Corp. (NYSE:AVD) for 4,600 shares. Blackrock Fund Advsr accumulated 1.77M shares or 0.01% of the stock.

Insider Transactions: Since August 16, 2016, the stock had 1 buying transaction, and 2 sales for $76,150 net activity. Shares for $79,550 were bought by Trogele Ulrich on Friday, September 9. 5,000 shares with value of $86,700 were sold by Rizzi John on Tuesday, August 30. Hendrix Scott sold $69,000 worth of American Vanguard Corp. (NYSE:AVD) on Tuesday, August 16.

American Vanguard Corporation operates as a holding company. The company has a market cap of $540.61 million. The Firm conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC CV (AMVAC CV), AMVAC Netherlands BV (AMVAC BV) and Envance Technologies, LLC (Envance). It has a 44.67 P/E ratio. The Company, through AMVAC, develops and markets products for agricultural, commercial and consumer uses.

According to Zacks Investment Research, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms.”

AVD Company Profile

American Vanguard Corporation (AVD), incorporated on January 2, 1969, operates as a holding company. The Firm conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC CV (AMVAC CV), AMVAC Netherlands BV (AMVAC BV) and Envance Technologies, LLC (Envance). The Company, through AMVAC, develops and markets products for agricultural, commercial and consumer uses. The Firm makes and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals, which include insecticides, fungicides, herbicides, molluscicides, growth regulators and soil fumigants, are marketed in liquid, powder and granular forms.

Another recent and important American Vanguard Corp. (NYSE:AVD) news was published by Thestreet.com which published an article titled: “Commit To Purchase American Vanguard Corp. At $12.50, Earn 11.2% Annualized …” on November 04, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>